Acceleron Pharma Inc.
TGFBETA AND ACTRII ANTAGONISTS FOR USE IN INCREASING IMMUNE ACTIVITY

Abstract:

Disclosed herein are TGF.beta. and ActRII antagonists and methods for increasing immune responses and/or activity in patients in need thereof including, for example, cancer patients.